Corrigendum: Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bands

Corrigendum: Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bands

Bibliographic Details
Main Authors:	Fay Probert, Tianrong Yeo, Yifan Zhou, Megan Sealey, Siddharth Arora, Jacqueline Palace, Timothy D. W. Claridge, Rainer Hillenbrand, Johanna Oechtering, Jens Kuhle, David Leppert, Daniel C. Anthony
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Immunology
Subjects:	diagnosis metabolomics (OMICS) multiple sclerosis (MS) proteomics oligoclonal band biomarker
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.1095038/full

Similar Items

Determination of CSF GFAP, CCN5, and vWF Levels Enhances the Diagnostic Accuracy of Clinically Defined MS From Non-MS Patients With CSF Oligoclonal Bands
by: Fay Probert, et al.
Published: (2022-02-01)

CSF oligoclonal IgG bands are not associated with ALS progression and prognosis
by: Veronika Klose, et al.
Published: (2023-05-01)

Kappa Index versus CSF Oligoclonal Bands in Predicting Multiple Sclerosis and Infectious/Inflammatory CNS Disorders
by: Diana Ferraro, et al.
Published: (2020-10-01)

The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis
by: Lorenzo Gaetani, et al.
Published: (2023-12-01)

The Effect of Oligoclonal Bands in Patients with Multiple Sclerosis
by: Nurhan Kaya Tutar, et al.
Published: (2022-12-01)

Absence of Oligoclonal Bands in Multiple Sclerosis: A Call for Differential Diagnosis
by: Evangelos Katsarogiannis, et al.
Published: (2023-07-01)

IgA lambda oligoclonal gammopathy in multiple myeloma
by: İbrahim Tek, et al.
Published: (2010-06-01)

USEFULNESS OF ISOELECTRIC-FOCUSING IN POLYACRYLAMIDE-GEL (IEF-PAGE) IN DEMONSTRATING OLIGOCLONAL BANDING IN MS CSF
by: Ebers, G, et al.
Published: (1979)

Improving Biologics’ Effectiveness in Clinical Oncology: From the Combination of Two Monoclonal Antibodies to Oligoclonal Antibody Mixtures
by: Christel Larbouret, et al.
Published: (2021-09-01)

Characteristics of cerebrospinal fluid oligoclonal band in anti-myelin oligodendrocyte glycoprotein (MOG) antibody associated disease
by: Wenjun Shao, et al.
Published: (2024-03-01)

Evaluation of semi-automatic image analysis tools for cerebrospinal fluid electrophoresis of IgG oligoclonal bands
by: G. Forzy, et al.
Published: (2018-03-01)

Evidence of Oligoclonal Bands Does Not Exclude Non-Inflammatory Neurological Diseases
by: Katharina Pannewitz-Makaj, et al.
Published: (2020-12-01)

Concordance rate between oligoclonal bands and the Kappa index in patients with suspected multiple sclerosis (MS)
by: Renan Barros Domingues, et al.
Published: (2024-03-01)

Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis
by: Clàudia Coll‐Martinez, et al.
Published: (2021-12-01)

Cerebrospinal fluid oligoclonal bands in Chinese patients with multiple sclerosis: the prevalence and its association with clinical features
by: Xiang Zhang, et al.
Published: (2023-11-01)

Differentiating neurosarcoidosis from multiple sclerosis using combined analysis of basic CSF parameters and MRZ reaction
by: Benjamin Vlad, et al.
Published: (2023-03-01)

Oligoclonal Band Straightening Based on Optimized Hierarchical Warping for Multiple Sclerosis Diagnosis
by: Farah Haddad, et al.
Published: (2022-01-01)

Cerebrospinal Fluid IgM and Oligoclonal IgG Bands in Multiple Sclerosis: A Meta-Analysis of Prevalence and Prognosis
by: Mattia Fonderico, et al.
Published: (2021-10-01)

Oligoclonal Band Status and Features of Radiological and Clinical Findings in Patients with Multiple Sclerosis in Lithuania
by: Emilija Aleksandravičiūtė, et al.
Published: (2023-05-01)

Oligoclonal banding in MS.
by: Ebers, G
Published: (1984)

Oligoclonal M bands and cervical spinal cord lesions predict early secondary progressive multiple sclerosis
by: Carmen Alcalá Vicente, et al.
Published: (2022-10-01)

Comparing clinical features, severity and prognosis of autoimmune encephalitis and with and without oligoclonal bands
by: Hongfei Xue, et al.
Published: (2024-01-01)

Basic CSF parameters and MRZ reaction help in differentiating MOG antibody-associated autoimmune disease versus multiple sclerosis
by: Benjamin Vlad, et al.
Published: (2023-09-01)

AGAROSE ISOELECTRIC-FOCUSING - AN IMPROVED METHOD FOR THE DETECTION OF OLIGOCLONAL BANDS IN CSF
by: Voulters, L, et al.
Published: (1983)

Establishing the best combination of the kappa free light chain index and oligoclonal bands for an accurate diagnosis of multiple sclerosis
by: Enric Monreal, et al.
Published: (2023-10-01)

‘Hummingbird’ Sign in a Patient with Guam Parkinsonism-Dementia Complex
by: Tianrong Yeo, et al.
Published: (2017-09-01)

Integrative biochemical, proteomics and metabolomics cerebrospinal fluid biomarkers predict clinical conversion to multiple sclerosis
by: Probert, F, et al.
Published: (2021)

Comparing clinical and imaging features of patients with MOG antibody-positivity and with and without oligoclonal bands
by: Yuji Tomizawa, et al.
Published: (2023-07-01)

Associations of HLA DRB1 alleles with IgG oligoclonal bands and their influence on multiple sclerosis course and disability status
by: Renata Balnytė, et al.
Published: (2016-01-01)

Lower levels of vWF are associated with lower risk of cardiovascular disease
by: Pauline C. S. vanParidon, et al.
Published: (2022-10-01)

Single-cell transcriptomics combined with proteomics of intrathecal IgG reveal transcriptional heterogeneity of oligoclonal IgG-secreting cells in multiple sclerosis
by: Justyna Polak, et al.
Published: (2023-06-01)

Comparison of polyacrylamide and agarose support media for detection of oligoclonal IgG bands in CSF.
by: North, J, et al.
Published: (1987)

A Comparison of IgG Index and Oligoclonal Band in the Cerebrospinal Fluid for Differentiating between RRMS and NMOSD
by: Bo Chen, et al.
Published: (2021-12-01)

Progressive Encephalomyelitis with Rigidity and Myoclonus in an Intellectually Disabled Patient Mimicking Neuroleptic Malignant Syndrome
by: Zheyu Xu, et al.
Published: (2017-05-01)

Whole-Transcriptome Analysis in Peripheral Blood Mononuclear Cells from Patients with Lipid-Specific Oligoclonal IgM Band Characterization Reveals Two Circular RNAs and Two Linear RNAs as Biomarkers of Highly Active Disease
by: Leire Iparraguirre, et al.
Published: (2020-11-01)

An Updated Evaluation of Intrathecal IgG Synthesis Markers in Relation to Oligoclonal Bands
by: Fotini Boufidou, et al.
Published: (2023-01-01)

Expression of vWF in transplanted human lung cancer with the different metastatic potential
by: SI Xiao-li, LI Shuang-yan, GUO Chao, ZHANG Song, ZHANG Li
Published: (2020-03-01)

Endothelial dysfunction markers (VCAM-1, vWF) in chronic hepatitis C
by: T V Antonova, et al.
Published: (2013-12-01)

Distribution and history of extensional stresses on vWF surrogate molecules in turbulent flow
by: Oanh L. Pham, et al.
Published: (2022-01-01)

An immuno-enrichment free, validated quantification of tau protein in human CSF by LC-MS/MS
by: Wade Self, et al.
Published: (2022-01-01)